JP Morgan Chase
MTEM

JP Morgan Chase’s Molecular Templates, Inc. MTEM Stock Holding History

JP Morgan Chase’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-37
Closed -$52 – 7903
2024
Q3 		$52 Hold
37
– – ﹤0.01% 7119
2024
Q2 		$43 Hold
37
– – ﹤0.01% 7053
2024
Q1 		$83 Hold
37
– – ﹤0.01% 6943
2023
Q4 		$137 Hold
37
– – ﹤0.01% 7091
2023
Q3 		$234 Sell
37
-3
-8% -$24 ﹤0.01% 6823
2023
Q2 		$288 Hold
40
– – ﹤0.01% 6600
2023
Q1 		$0 Hold
40
– – ﹤0.01% 7415
2022
Q4 		$0 Sell
40
-152
-79% -$1.26K ﹤0.01% 7203
2022
Q3 		$2K Buy
192
+41
+27% +$515 ﹤0.01% 6284
2022
Q2 		$2K Sell
151
-15,917
-99% -$372K ﹤0.01% 6323
2022
Q1 		$832K Sell
16,068
-126
-0.8% -$5.57K ﹤0.01% 4396
2021
Q4 		$952K Sell
16,194
-967
-6% -$72.4K ﹤0.01% 4431
2021
Q3 		$1.73M Sell
17,161
-4,056
-19% -$418K ﹤0.01% 3904
2021
Q2 		$2.49M Sell
21,217
-787
-4% -$103K ﹤0.01% 3636
2021
Q1 		$4.17M Buy
22,004
+16,154
+276% +$2.83M ﹤0.01% 3128
2020
Q4 		$823K Buy
5,850
+180
+3% +$26.6K ﹤0.01% 4075
2020
Q3 		$893K Buy
5,670
+1,953
+53% +$347K ﹤0.01% 3706
2020
Q2 		$769K Sell
3,717
-3,548
-49% -$824K ﹤0.01% 3656
2020
Q1 		$1.45M Buy
7,265
+6,893
+1,853% +$1.51M ﹤0.01% 3183
2019
Q4 		$78K Sell
372
-7,704
-95% -$1.11M ﹤0.01% 4980
2019
Q3 		$798K Buy
8,076
+1,087
+16% +$101K ﹤0.01% 3957
2019
Q2 		$817K Sell
6,989
-1,677
-19% -$182K ﹤0.01% 3978
2019
Q1 		$755K Sell
8,666
-3,263
-27% -$239K ﹤0.01% 3970
2018
Q4 		$723K Buy
11,929
+5,967
+100% +$416K ﹤0.01% 3936
2018
Q3 		$482K Buy
5,962
+5,408
+976% +$415K ﹤0.01% 4298
2018
Q2 		$44K Sell
554
-2,781
-83% -$315K ﹤0.01% 5124
2018
Q1 		$400K Buy
3,335
+976
+41% +$147K ﹤0.01% 4111
2017
Q4 		$355K Buy
2,359
+1,635
+226% +$205K ﹤0.01% 4218
2017
Q3 		$70K Buy
+724
New +$62.5K ﹤0.01% 4397
2016
Q2 		– Sell
-7,837
Closed -$595K – 5025
2016
Q1 		$595K Sell
7,837
-516
-6% -$30.5K ﹤0.01% 3289
2015
Q4 		$662K Buy
8,353
+5,638
+208% +$2.78M ﹤0.01% 3289
2015
Q3 		$1.82M Sell
2,715
-43
-2% -$30.6K ﹤0.01% 2794
2015
Q2 		$1.84M Sell
2,758
-733
-21% -$484K ﹤0.01% 2957
2015
Q1 		$2.34M Sell
3,491
-571
-14% -$376K ﹤0.01% 2798
2014
Q4 		$2.13M Sell
4,062
-11,284
-74% -$5.64M ﹤0.01% 2926
2014
Q3 		$9.14M Sell
15,346
-2,767
-15% -$1.91M ﹤0.01% 1983
2014
Q2 		$11.8M Sell
18,113
-976
-5% -$647K ﹤0.01% 1662
2014
Q1 		$15M Sell
19,089
-48
-0.3% -$39K ﹤0.01% 1496
2013
Q4 		$14.7M Buy
19,137
+37
+0.2% +$27.9K ﹤0.01% 1526
2013
Q3 		$14.7M Sell
19,100
-3,054
-14% -$2.51M ﹤0.01% 1507
2013
Q2 		$19.2M Buy
+22,154
New +$18.7M 0.01% 1273

Other funds holding MTEM

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

JP Morgan Chase's MTEM Position: Q4 2024 in Review

JP Morgan Chase sold out of Molecular Templates, Inc. (MTEM) in Q4 2024, closing a stake of 37 shares — an estimated $52 sold.

JP Morgan Chase first reported a position in MTEM in Q2 2013 and held it in 41 quarters. The position peaked at $19.2M in Q2 2013. 3 funds tracked by Wall St. Rank hold MTEM as of Q4 2024.

  • JP Morgan Chase reported no remaining Molecular Templates, Inc. position as of Q4 2024 after selling out during the quarter.
  • JP Morgan Chase sold 37 Molecular Templates, Inc. shares in Q4 2024, an estimated $52.
  • JP Morgan Chase first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 41 quarters.
  • JP Morgan Chase's Molecular Templates, Inc. position peaked at $19.2M in Q2 2013.
  • 3 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2024.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.